Charlotte Irvine

Cooley advised Battery Ventures, a global investment firm focusing on technology, on its acquisition of GrammaTech’s software products division, including the CodeSonar and CodeSentry product lines.

Cooley advised Snyk, a leader in developer security, on its acquisition of Enso Security, pioneers of the industry’s first application security posture management (ASPM) solution.

Cooley advised Exscientia, an AI-driven pharmatech company based in Oxford, United Kingdom, on its $510.4 million initial public offering, including concurrent private placements to SoftBank and the Bill & Melinda Gates Foundation. Partners David Boles, Claire Keast-Butler, Div Gupta and Marc Recht led the Cooley team advising Exscientia.

Cooley advised Exscientia, a clinical-stage pharmatech company, on its $225 million Series D funding round led by SoftBank Vision Fund 2, which is also providing an additional $300 million equity commitment that can be drawn at Exscientia’s discretion. Lawyers Claire Keast-Butler and Tom Goodman led the Cooley team advising Exscientia.